ICRA has maintained Mawana Sugars' rating at BBB with a stable outlook, indicating the company's strong ability to repay its ₹500 crore working capital debt. This reassurance highlights the sugar manufacturer's solid financial position.

Ind Swift Labs has successfully defended itself in a dispute with PI Industries, as the tribunal ruled in its favor. This decision brings an end to any potential financial implications for Ind Swift.

Alembic Pharma has secured USFDA approval for Dapagliflozin tablets, a diabetes drug similar to AstraZeneca's Farxiga. This move grants them a 180-day shared exclusivity in the market, targeting potential sales of up to $10.5 billion by December 2025.

ICICI Securities recommends investing in large private banks like HDFC and Kotak due to their robust financial health and promising risk-reward prospects. Smaller banks such as RBL, Bandhan, City Union, Karur Vysya, DCB, and South Indian Bank are rated as 'Buy', but potential risks from small businesses and geopolitical factors are being closely monitored.

Goldman Sachs has boosted its recommendation on TVS Motor to 'Buy', expecting a 21% increase in share price due to robust volume growth and premium product launches. The firm anticipates margin improvements thanks to PLI incentives, but warns of potential challenges from commodity inflation and increased competition.

ICICI Pru and Nippon AMC are seeing growth in Q1 due to consistent inflows, despite MTM losses and lower yields. On the flip side, UTI AMC and Canara Robeco AMC are experiencing a decline in market share due to performance shortcomings.

HDFC Bank reported a significant increase in both deposits and advances for Q4, with deposits growing by 15.5% year-on-year to ₹20.45 lakh crore and advances rising by 12% YoY to ₹29.64 lakh crore.

Birlasoft's recent financial performance shows a struggle, with a slow growth rate compared to peers and even a contraction in FY25. Additionally, the departure of top executives and the absence of an AI strategy under CEO Angan Guha might be hindering efforts towards a turnaround.

Anticipation builds for TCS's Q4 results on April 9. Investors are keen to see progress in deal wins, margin stability, and potential dividends. Notably, Kotak Securities has set a target price of Rs 3,090 for the tech giant. Brokerages expect TCS's EBIT margin to remain steady.

Uno Minda Ltd has been issued a GST notice for an excessive Input Tax Credit claim in the fiscal year 2019-20, amounting to approximately INR 51 lakhs. The order includes a tax demand of INR 16.1 lakhs, a penalty of the same amount, and interest totaling INR 18.7 lakhs. However, the company intends to contest this decision.

Both Marico and Dabur, prominent Fast-Moving Consumer Goods (FMCG) firms, anticipate a robust single-digit growth in Q4 of the financial year 2025-26. Despite geopolitical challenges in West Asia, their domestic operations seem to be holding strong, mitigating these risks.

DAM Capital has recommended buying cement stocks due to anticipated price increases of Rs. 30-50 per bag and favorable valuations, potentially leading to a 7.4%-21.9% increase in shares for companies like UltraTech Cement, JSW Cement, Shree Cement, Ambuja, Dalmia Bharat, and Nuvoco.

Nomura has raised concerns about margin pressures for oil marketing companies (IOCL, BPCL, HPCL) due to rising prices of ATF and LPG, along with subsidy burdens. On the other hand, Petronet LNG is expanding its capacity to 22.5 mtpa, while Reliance Industries' SEZ refinery has been exempted from windfall tax, boosting their margins.

RBL Bank experienced a significant boost in derivative trades, up by 11.3%, signaling increased engagement from investors. However, the bank's performance lagged behind its sector and broader market indices, indicating potential challenges ahead.

Axis Max Life is selling shares worth Rs. 389 crore to Axis Bank, a move expected to bolster growth. Post-issue, Axis Bank entities will hold approximately 20% of Axis Max Life's equity, with each share priced at Rs. 151.9.

Citi recommends buying shares in Hindustan Aeronautics due to a positive forecast, driven by increased orders, a solid order backlog, and high demand for repairs. The target price is set at Rs 5,560.

GRSE achieved an all-time high turnover in the fiscal year 2026, indicating a robust financial standing. This notable achievement underscores their strong performance during this period.

The Defense index saw a significant 7% rise today, primarily driven by GRSE's impressive 19% surge, Cochin Shipyard's 15% gain, and Mazagon Dock's 13.5% boost. Notably, Bharat Electronics (BEL) secured new contracts worth ₹6,795 crore. Additionally, GRSE's revenue for the fiscal year 2026 increased by 26% year-over-year, and Midhani reported a 12.3% year-over-year growth. Analysts express optimism towards BEL, Midhani, and Solar Industries due to their demonstrated strong execution.

Bharat Dynamics Ltd has announced that its General Manager - Human Resources, Shri N. Satyanarayana, will retire on March 31, 2026. The company has made this disclosure according to Regulation 30 of SEBI LODR, 2015, signaling a change in senior management within the organization.

Marksans Pharma has received U.S. FDA approval for Benzonatate Capsules, expanding their product portfolio in the American market. This approval could potentially increase their market presence and revenue stream in the US pharmaceutical sector.